FOSTER CITY, Calif.--(BUSINESS WIRE)--March 21, 2006--OXIS International (OTCBB:OXIS) (Nouveau Marche:OXIS) (FWB:OXI), a biopharmaceutical company focused on commercializing research assays, nutraceutical and therapeutic products related to oxidative stress and, through its majority interest in BioCheck, a leading provider of high quality immunoassay clinical kits and contract services, today announced the appointment of Gary Post, Managing Director and Investment Principal of Ambient Advisors, LLC to the Company’s Board of Directors. Ambient invests its own and its partners’ capital in private and public companies with a particular interest in the health care and life sciences sector. Ambient also actively advises these companies, sometimes taking interim management roles.
